CCL2 and cancer: In conclusion, the interplay between these inflammatory mediators—IL-6, IL-1β, TNF-α, CCL2, PGE2, GM-CSF, and bradykinin—highlights their collective role in the mechanisms underlying cancer pain (Fig. 3).